Showing results (31-40 of 117) with videos related to
Sort By:
Pageof 12
Internal Medicine (Tokyo, Japan)|September 21, 2022
A Transanal Endoscopic Ultrasound-guided Fine-needle Aspiration Biopsy for an Intrapelvic Tumor Diagnosed as Recurrence of a Smooth Muscle Tumor of Uncertain Malignant Potential Following Uterine MorcellationTesshin Ban, Yoshimasa Kubota, Daikoh Okubo, et al.Anticancer Research|May 18, 2012
The relationship between antitumor effects and relative dose intensity of S-1 plus cisplatin treatment for metastatic gastric cancerMika Kitagawa, Takaya Shimura, Tomonori Yamada, et al.Medicine|August 11, 2017
Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapyTsutomu Mizoshita, Takahito Katano, Satoshi Tanida, et al.Journal of Clinical Gastroenterology|November 5, 2008
Gastroesophageal and laryngopharyngeal reflux symptoms correlate with histopathologic inflammation of the upper and lower esophagusTsuneya Wada, Makoto Sasaki, Hiromi Kataoka, et al.Internal Medicine (Tokyo, Japan)|May 17, 2013
Maintenance of the remission stage of Crohn's disease with adalimumab therapy during pregnancyTsutomu Mizoshita, Satoshi Tanida, Hironobu Tsukamoto, et al.Internal Medicine (Tokyo, Japan)|November 2, 2011
A rare case of infectious colitis with ulcers in the cecum caused by Mycobacterium gordonaeTsutomu Mizoshita, Satoshi Tanida, Takashi Mizushima, et al.Clinical Journal of Gastroenterology|July 21, 2015
Successful treatment for pouchitis with rebamipide refractory to a combination of metronidazole (MNZ) and ciprofloxacin (CFX)Naotaka Ogasawara, Makoto Sasaki, Yasutaka Hijikata, et al.Case Reports in Gastroenterology|July 28, 2016
Long-Term Clinical Remission in Biologically Naïve Crohn's Disease Patients with Adalimumab Therapy, Including Analyses of Switch from Adalimumab to InfliximabTsutomu Mizoshita, Satoshi Tanida, Keiji Ozeki, et al.Journal of Clinical Medicine Research|February 4, 2020
Combination Therapy With Tofacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction Therapy for Refractory Ulcerative ColitisSatoshi Tanida, Keiji Ozeki, Tsutomu Mizoshita, et al.Journal of Clinical Medicine Research|January 8, 2024
Upadacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis for Ulcerative Colitis Achieved Ulcer Healing for Pyoderma GangrenosumSatoshi Tanida, Ryoji Kubo, Shoichiro Yoshii, et al.Pageof 12